S100P and colorectal carcinoma: In turn, we analysed the S100P expression in microdissected mRNA samples of CRC patients without synchronous metastasis at the time of diagnosis (UICC I–III) but observed no significant alteration of S100P expression in patients with or without metachronous metastasis (P = 0.16; N = 60; Fig. 5a, left).